U
SomnoMed Limited SOMNF
$0.4361 -$0.0487-10.05% OTC PK
Recommendation
Prev Close
--
Volume
Avg Vol (90D)
--
Market Cap
Dividend & Yield
--
52-Week Range
-- - --
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income 43.74% 3.24% -49.01% -66.86% -95.92%
Total Depreciation and Amortization 12.71% 19.16% 24.35% 18.08% 12.52%
Total Amortization of Deferred Charges 4.80% 4.80% 4.80% 48.39% 175.77%
Total Other Non-Cash Items -4.19% -37.79% -89.31% 403.08% 198.49%
Change in Net Operating Assets 66.74% 66.74% 66.74% -256.61% -254.93%
Cash from Operations 146.41% 56.37% -59.14% -108.80% -248.18%
Capital Expenditure 18.07% 42.16% 56.89% 43.95% 26.55%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -10.69% -15.48% -17.78% 41.42% 66.11%
Cash from Investing 0.94% 10.70% 18.76% 42.27% 56.69%
Total Debt Issued -- -- -- -99.20% -98.57%
Total Debt Repaid -69.16% -94.78% -119.70% -66.36% -7.44%
Issuance of Common Stock 61.28% 322.57% -- 26,325,500.00% 7,286,600.00%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 11.68% 84.14% 147.31% 21.16% -49.13%
Foreign Exchange rate Adjustments 224.36% 124.73% -30,017.65% -50.40% 25.55%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 235.83% 224.08% 211.09% 102.05% -389.56%